Making an IMPACT in ALL therapy: how can cure rates be improved?
Copanlisib produces promising results in relapsed/refractory follicular lymphoma
Generics for chronic myeloid leukemia treatment – a hot topic at ASH 2016 as imatinib patent expires
ADCT-402 - a drug to watch
Importance of taking into consideration new and traditional treatment options for CLL patients